Your browser doesn't support javascript.
loading
TAS0314, a novel multi-epitope long peptide vaccine, showed synergistic antitumor immunity with PD-1/PD-L1 blockade in HLA-A*2402 mice.
Tanaka, Yuki; Wada, Hiroshi; Goto, Risa; Osada, Toshihiro; Yamamura, Keisuke; Fukaya, Satoshi; Shimizu, Atsushi; Okubo, Mitsuru; Minamiguchi, Kazuhisa; Ikizawa, Koichi; Sasaki, Eiji; Utsugi, Teruhiro.
Afiliación
  • Tanaka Y; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan. yuuki-tanaka@taiho.co.jp.
  • Wada H; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
  • Goto R; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
  • Osada T; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
  • Yamamura K; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
  • Fukaya S; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
  • Shimizu A; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
  • Okubo M; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
  • Minamiguchi K; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
  • Ikizawa K; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
  • Sasaki E; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
  • Utsugi T; Discovery and Preclinical Research Division, Taiho Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, Japan.
Sci Rep ; 10(1): 17284, 2020 10 14.
Article en En | MEDLINE | ID: mdl-33057061
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Vacunas de Subunidad / Antígeno HLA-A24 / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Neoplasias Límite: Animals / Female / Humans Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Vacunas de Subunidad / Antígeno HLA-A24 / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Neoplasias Límite: Animals / Female / Humans Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Japón